Akebia Therapeutics | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Akebia Therapeutics | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Updated January 19, 2026
Public ProfileLinkedInLinkedIn Profile

Akebia Therapeutics, Inc.

Employees97
Revenue$160.2M
Market Cap411.3M

Industry & Market

Primary Industry
research
All Industries
researchbiotechnology
Location
Cambridge, Massachusetts, United States
Public Trading
NASDAQ: AKBA

Funding Information

Annual Revenue
$160,180,000
Publicly traded company

Headcount Distribution

Total Employees
97
Departments
19

By Department

Department Breakdown

Operations
Sales
Accounting
Legal
Education
Finance
Others

Keywords & Focus Areas

healthcarebiotechnologylife sciencesbiotechnology: pharmaceutical preparationshealth carebiotechnology researchoral hif-phichronic kidney diseasemedical product developmentresearch and development in the physical, engineering, and life sciencesclinical research in kidney diseasetherapeutic innovation in nephrologytherapeutic innovationanemia therapyvadadustatckd treatmentbiotech leadershipbiopharmaceuticalanemia in ckdmedical breakthroughs+10 more
30 total keywords

Overview

Akebia Therapeutics, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, founded in 2007. The company focuses on developing and commercializing innovative therapeutics for patients with kidney disease, particularly addressing anemia associated with chronic kidney disease (CKD). It aims to set new standards of care in nephrology through its dedicated commercial team and strong development organization.

The company has two FDA-approved products: Vafseo, an oral HIF-PH inhibitor for treating anemia due to CKD, and Auryxia, which is used for hyperphosphatemia and iron deficiency anemia in CKD patients. Its mission is to transform the lives of CKD patients by targeting unmet needs in the renal space. With a commitment to innovation, Akebia positions itself as an industry leader, competing with larger firms in the dialysis market.

Key Metrics

Total Employees
XXXX
Total number of employees
Engineering
XX
Number of employees in the engineering department
Sales Team
$XX
Number of employees in the sales department
Marketing
XX
Number of employees in the marketing department
Founded
XXXX
Year the company was founded
Revenue
$XXX,XXX,XXX
Total revenue of the company
Total Funding
$XXX M
Total funding of the company
Market Cap
$XXX,XXX
Market cap of the company

Get Complete Company Metrics

Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.

Start For Free

Contact

Company
Akebia Therapeutics
Headquarters
245 First Street, Suite 1400, Cambridge, MA 02142, US
Founded
2007
Languages
English
Industry
research

Technology Stack

Analytics & Tracking

Google Tag Manager

Social & Marketing

Not found

Database & Backend

Google Font APIOneTrust

Cloud & Infrastructure

Not found

Productivity

Not found

Compare similar companies to Akebia Therapeutics

Compare insights from companies similar to Akebia Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company NameRevenueNo. of EmployeesTypeFundingFounded InTop Executive
xxxxxx
$21223132Private-4226
xxxxxx
xxxxxxxx
$16745147Private-4509
xxxx
xxxxxxx
$79639146Private-8041
xxxxxx
xxxx
$9992358Private-1736
xxxxxx
xx
$61346124Private-9562
xx

Discover Similar Companies Instantly

Explore detailed insights and analysis on companies related to your search.

Start For Free

Turn this profile into a pipeline

Find decision makers, more insights and contact information about this company on Bitscale

Start For Free

Schedule your demo now!

See how BitScale can supercharge your outbound sales in a 30-minute demo

Start for Free

Resources

Careers

Pricing

homeCommunity

Security

SayData

© 2026 Bitscale. Featherflow Technology Pvt Ltd.

LinkedInTwitterInstagramYouTube
AICPAGDPR
CCPAISO
LinkedInTwitterInstagramYouTube